2-n-substituted or unsubstituted-2-amino-5-methylpiperidine-3,4-diols and processes for the preparation thereof
AssigneesZaidan Hojin Biseibutsu Kagaku Kenkyu Kai, Meiji Seika Kaisha, Ltd.
InventorsYoshio Nishimura, Eiki Shitara, Tomio Takeuchi
Life of this patent
Estimating the term…
Abstract
This invention relates to (2R,3S,4R,5R)-2-amino-5-methylpiperidine-3,4-diol or a (2S,3S,4R,5R)-2-N-substituted-2-amino-5-methylpiperidine-3,4-diol represented by the general formula (I): wherein R1 and R2 each are a hydrogen atom, or R1 is a hydrogen atom and R2 is a lower alkanoyl group or a lower ω-trihaloalkanoyl group, or R1 and R2 together denote phthaloyl group, and a pharmaceutically acceptable salt thereof. Said compound can be prepared from a (2S,3S,4R)-5-N-protected-2,3,4-O-tri-protected-5-aminopentane-1,2,3,4-tetraol by multi-steps of reactions.
Claims13
(2R,3S,4R,5R)-2-Amino-5-methylpiperidine-3,4-diol or a (2S,3S,4R,5R)-2-N-substituted-2-amino-5-methylpiperidine-3,4-diol represented by formula (I):
- wherein R1 and R2 each are a hydrogen atom, or R1 is a hydrogen atom and R2 is a lower alkanoyl group or a lower ω-trihaloalkanoyl group, or R1 and R2 together denote a phthaloyl group, or a pharmaceutically acceptable salt thereof.
A (2S,3S,4S)-1-N-protected-3,4-O-di-protected-5-methylene-2-phthalimidopiperidine-3,4-diol represented by formula (IX):
- wherein R3 is an imino-protecting group, and X1 and X2 each are a hydroxyl-protecting group, or X1 and X2 together denote a divalent hydroxyl-protecting group.
A process for the preparation of (2R,3S,4R,5R)-2-amino-5-methylpiperidine-3,4-diol or a (2S,3S,4R,5R)-2-N-substituted-2-amino-5-methylpiperidine-3,4-diol represented by formula (I):
- wherein R1 and R2 each are a hydrogen atom, or R1 is a hydrogen atom and R2 is a lower alkanoyl group or a lower ω-trihaloalkanoyl group, or R1 and R2 together denote phthaloyl group, characterized in that the process comprises:
- eliminating the hydroxyl-protecting group (R4) at the 4-position of a (2S,3S or 3R,4R)-5-N-protected-2,3,4-O-tri-protected-5-aminopentane-1,2,3,4-tetraol represented by formula (II):
- wherein R3 is an amino-protecting group, R4 is a hydroxyl-protecting group, and X1 and X2 each are a hydroxyl-protecting group, or X1 and X2 together denote one divalent hydroxyl-protecting group having the formula:
- where R5 and R6 may be the same or different and each denote a hydrogen atom, an alkyl group or an aryl group, especially phenyl group, or X1 and X2 together denote a cycloalkylidene group or tetrapyranylidene group, to give a (2S,3R,4R)-5-N-protected-2,3-O-di-protected-5-aminopentane-1,2,3,4-tetraol represented by formula (III):
- wherein R3, X1 and X2 have the same meanings as above;
- protecting the hydroxyl group at the 1-position of the compound of formula (III) with a hydroxyl-protecting group (R7), to prepare a (2S,3R,4R)-5-N-protected-1,2,3-O-tri-protected-5-aminopentane-1,2,3,4-tetraol represented by formula (IV):
- wherein R3, X1 and X2 have the same meanings as above and R7 denotes a hydroxyl-protecting group;
- oxidizing the hydroxyl group at the 4-position of the compound of formula (IV), to prepare a (2S,3S)-5-N-protected-1,2,3-O-tri-protected-4-keto-5-aminopentane-1,2,3-triol represented by formula (V):
- wherein R3, X1, X2 and R7 have the same meanings as above;
- subjecting the oxo group at the 4-position of the compound of formula (V) to the Wittig reaction so as to convert the oxo group into a methylene group, thereby producing a (2S,3S)-5-N-protected-1,2,3-O-tri-protected-4-methylene-5-aminopentane-1,2,3-triol represented by formula (VI):
- wherein R3, R7, X1 and X2 have the same meanings as above;
- eliminating the hydroxyl-protecting group (R7) at the 1-position of the compound of formula (VI), to prepare a (2S,3S)-5-N-protected-2,3-O-di-protected-4-methylene-5-aminopentane-1,2,3-triol represented by formula (VII):
- wherein R3, X1 and X2 have the same meanings as above;
- oxidizing the hydroxyl group at the 1-position of the compound of formula (VII) with accompanying cyclization, to prepare a (2R,3R,4S)-1-N-protected-3,4-O-di-protected-5-methylenepiperidine-2,3,4-triol represented by formula (VIII):
- wherein R3, X1 and X2 have the same meanings as above;
- conducting the Mitsunobu reaction on the hydroxyl group at the 2-position of the compound of formula (VIII) by reaction with phthalimide, to prepare a (2S,3S,4S)-1-N-protected-3,4-O-di-protected-5-methylene-2-phthalimido-piperidine-3,4-diol represented by formula (IX):
- wherein R3, X1 and X2 have the same meanings as above;
- reducing the double bond at the 5-position of the compound of formula (IX) to convert the methylene group at the 5-position into a methyl group, thereby preparing a (2S,3S,4R,5R)-1-N-protected-3,4-O-di-protected-5-methyl-2-phthalimidopiperidine-3,4-diol represented by formula (X):
- wherein R3, X1 and X2 have the same meanings as above;
- eliminating the phthaloyl group from the 2-amino group of the compound of formula (X) by treatment with hydrazine or an acid, to prepare a (2R,3S,4R,5R)-2-amino-1-N-protected-3,4-O-di-protected-5-methylpiperidine-3,4-diol represented by formula (XI):
- wherein R3, X1 and X2 have the same meanings as above;
- protecting the amino group at the 2-position of the compound of formula (XI) with a lower alkanoyl group or a lower ω-trihaloalkanoyl group (R2), to prepare a compound represented by formula (XII):
- wherein R3, X1 and X2 have the same meanings as above, R1 is a hydrogen atom and R2 is a lower alkanoyl group or a lower ω-trihaloalkanoyl group;
- and then
- eliminating both the imino-protecting group (R3) and the hydroxyl-protecting groups (X1 and X2) of the compound of formula (XII), or alternatively eliminating the imino-protecting group and the hydroxyl-protecting groups (X1 and X2) immediately from the compound of formula (X) or (XI), to give the compound of the formula (I).
Dependencies are inferred from the claim text.